|
|
|
|
|
|
Sponsors and Collaborators: |
University of Lausanne University Hospital Inselspital, Berne |
Information provided by: | University of Lausanne |
ClinicalTrials.gov Identifier: | NCT00558740 |
Individuals submitted to a high-fat or a high-fructose/sucrose diet develop, over a 6 day-period, several features of the metabolic syndrome, including increased plasma triglycerides, increased intrahepatic lipids, and decreased hepatic insulin sensitivity. It has been recently observed that the increase in intrahepatic lipids observed after a high fat diet is largely prevented when protein intake is concomitantly increased. This suggests that dietary protein protects the liver against some of the deleterious effects of a high fat diet. Mechanisms underlying this effect of protein may include an increased hepatic fat oxidation.
The aims of this study are:
Condition | Intervention |
Metabolic Syndrome X |
Other: high protein intake |
MedlinePlus related topics: | Dietary Proteins Metabolic Syndrome |
ChemIDplus related topics: | Fructose Lipids |
Study Type: | Observational |
Study Design: | Other, Prospective |
Official Title: | Effects of Dietary Proteins on Hepatic Lipid Metabolism |
Estimated Enrollment: | 22 |
Study Start Date: | May 2008 |
Estimated Study Completion Date: | December 2008 |
Groups/Cohorts | Assigned Interventions |
healthy volunteers |
Other: high protein intake
acute high protein intake chronic (6-day) high protein intake acute+chronic high protein intake control
|
Show Detailed Description |
Ages Eligible for Study: | 18 Years to 30 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Healthy volunteers
Inclusion Criteria:
Exclusion Criteria:
Contact: Luc Tappy, MD | 0041 21 692 55 41 | luc.tappy@unil.ch |
Switzerland, Vaud | |||||
Centre Hospitalier Universitaire Vaudois | Recruiting | ||||
Lausanne, Vaud, Switzerland, CH-1011 | |||||
Contact: Luc Tappy, MD 0041 21 692 55 41 luc.tappy@unil.ch |
University of Lausanne |
University Hospital Inselspital, Berne |
Principal Investigator: | l Tappy, MD | University of Lausanne |
Responsible Party: | Department of Physiology, University of Lausanne ( Prof. L uc Tappy ) |
Study ID Numbers: | protocol 66/07/CE/FBM, SNF 310000-109737 |
First Received: | November 14, 2007 |
Last Updated: | June 4, 2008 |
ClinicalTrials.gov Identifier: | NCT00558740 |
Health Authority: | Switzerland: Ethikkommision |
|
|
|
|